9913910 | Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron | Sep 19, 16 | Mar 13, 18 | HERON THERAPEUTICS, INC. |
9675588 | Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms | Mar 11, 15 | Jun 13, 17 | REDHILL BIOPHARMA LTD. |
9439920 | Composition for the management of nausea and vomiting | Oct 03, 14 | Sep 13, 16 | DUCHESNAY INC. |
9265724 | Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery | Sep 07, 10 | Feb 23, 16 | Not available |
9227958 | Amorphous and crystalline forms of aprepitant and processes for the preparation thereof | Feb 02, 07 | Jan 05, 16 | GLENMARK PHARMACEUTICALS LIMITED |
9066886 | Transdermal drug delivery system containing granisetron | Aug 22, 08 | Jun 30, 15 | TAHO PHARMACEUTICALS LTD. |
9066887 | Transdermal therapeutic system having urea components | Dec 09, 08 | Jun 30, 15 | LTS LOHMANN THERAPIE-SYSTEME AG |
9051273 | Phosphodiesterase 4 inhibitor capable of avoiding vomiting | Aug 25, 12 | Jun 09, 15 | GUANGZHOU LANSSON PHARMACEUTICAL CO., LTD. |
8901111 | Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase | Jun 04, 10 | Dec 02, 14 | JANSSEN PHARMACEUTICA NV |
8795634 | Absorption of therapeutic agents across mucosal membranes or the skin | Sep 14, 09 | Aug 05, 14 | CRITICAL PHARMACEUTICALS LIMITED |
8653063 | N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activity | Jan 22, 10 | Feb 18, 14 | ASKAT INC. |
8623826 | Compositions and methods for treating centrally mediated nausea and vomiting | Mar 31, 11 | Jan 07, 14 | HELSINN HEALTHCARE SA |
8372883 | Methods of using cycloalkylmethylamines | Jul 05, 11 | Feb 12, 13 | Reviva Pharmaceuticals, Inc. |
8304426 | Polymorphic form of Granisetron base, methods for obtaining it and formulation containing it | Dec 20, 07 | Nov 06, 12 | INKE, S.A. |
8278301 | 2-alkylbenzoxazole carboxamides as 5HT3 modulators | May 15, 09 | Oct 02, 12 | ALBANY MOLECULAR RESEARCH, INC., AMRI BOTHELL RESEARCH CENTER, INC., AMRI BURLINGTON, INC., AMRI RENESSELAER, INC., |
8252305 | Methods of treating emesis utilizing semi-solid delivery pharmaceutical compositions comprising granisetron | Oct 24, 11 | Aug 28, 12 | HERON THERAPEUTICS, INC., A.P. Pharma, |
8252306 | Process for preparing a semi-solid delivery vehicle comprising granisetron | Oct 24, 11 | Aug 28, 12 | HERON THERAPEUTICS, INC. |
8114866 | Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme | Feb 08, 10 | Feb 14, 12 | SANOFI |
8039460 | CGRP receptor antagonists | Oct 12, 05 | Oct 18, 11 | MERCK SHARP & DOHME CORP. |
8026212 | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues | Feb 04, 10 | Sep 27, 11 | ARENA PHARMACEUTICALS, INC. |